Supporting innovative and novel research to measure brain changes over longer periods, impacting neurodevelopment, aging, and disease risk in both humans and animals across all ages.
Funder: National Institutes of Health
Due Dates: February 16, 2027 (New) | March 16, 2027 (Resubmission/revision) | May 7, 2027 (Listing closes)
Funding Amounts: Up to $275,000 in direct costs over two years, with no more than $200,000 in any year
Summary: Supports innovative tools and methods for measuring brain changes in the same individuals across longer stretches of the lifespan.
Key Information: Projects must include in vivo measurements at two or more timepoints per participant or animal and annual milestones.
This NIH R21 exploratory/developmental program supports multidisciplinary research developing novel approaches—or innovative applications of existing approaches—to measure brain activity, connectivity, genomics, and other brain characteristics across longer timespans. Participating institutes are the National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Cancer Institute (NCI).
Projects may develop hardware, software, biological tools, or other experimental advances that link repeated brain measurements across the lifespan. The goal is to understand how earlier developmental stages predict later brain health and disease. Research may involve healthy people of any age, clinical populations, or animals. The program emphasizes high-risk, high-reward technological and conceptual innovation; preliminary data and a hypothesis-testing aim are not required.